D-Index & Metrics Best Publications
Masatoshi Hagiwara

Masatoshi Hagiwara

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Molecular Biology D-index 70 Citations 20,334 309 World Ranking 869 National Ranking 70

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • DNA

His primary scientific interests are in Molecular biology, Cell biology, Biochemistry, Protein kinase A and Kinase. His Molecular biology research incorporates themes from Ca2+/calmodulin-dependent protein kinase, Mitogen-activated protein kinase kinase, SR protein, RNA polymerase II and MAP kinase kinase kinase. His studies in Cell biology integrate themes in fields like CREB, Caenorhabditis elegans and Alternative splicing.

His work deals with themes such as RNA splicing and RNA-binding protein, which intersect with Alternative splicing. His Casein kinase 2, Casein kinase 2, alpha 1 and Open reading frame study in the realm of Biochemistry connects with subjects such as Recoverin and Neurocalcin. The study incorporates disciplines such as CLK1, Calmodulin and Serine in addition to Kinase.

His most cited work include:

  • Phosphorylated CREB binds specifically to the nuclear protein CBP (1846 citations)
  • Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. (1374 citations)
  • KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (575 citations)

What are the main themes of his work throughout his whole career to date?

Masatoshi Hagiwara spends much of his time researching Molecular biology, Biochemistry, Cell biology, Kinase and Protein kinase A. His study looks at the relationship between Molecular biology and topics such as Ca2+/calmodulin-dependent protein kinase, which overlap with Calmodulin. His study in Cell biology is interdisciplinary in nature, drawing from both Regulation of gene expression, RNA splicing and Caenorhabditis elegans.

Alternative splicing is closely connected to RNA-binding protein in his research, which is encompassed under the umbrella topic of RNA splicing. As a part of the same scientific study, he usually deals with the Kinase, concentrating on Phosphorylation and frequently concerns with CREB. His Protein kinase A study frequently intersects with other fields, such as Myosin light-chain kinase.

He most often published in these fields:

  • Molecular biology (27.38%)
  • Biochemistry (25.65%)
  • Cell biology (21.90%)

What were the highlights of his more recent work (between 2017-2021)?

  • Neuroscience (4.03%)
  • Cell biology (21.90%)
  • High-functioning autism (2.31%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Neuroscience, Cell biology, High-functioning autism, Spectrum disorder and RNA splicing. Masatoshi Hagiwara interconnects Astrocyte, Lung, Induced pluripotent stem cell, RNA-binding protein and Transcription in the investigation of issues within Cell biology. The various areas that Masatoshi Hagiwara examines in his RNA splicing study include Mutation, Molecular biology, Disease, Exon and Drug discovery.

The Molecular biology study which covers Gene knockdown that intersects with Intron. His biological study deals with issues like DNA, which deal with fields such as Alternative splicing. As a part of the same scientific family, Masatoshi Hagiwara mostly works in the field of Neurogenesis, focusing on Central nervous system and, on occasion, Kinase.

Between 2017 and 2021, his most popular works were:

  • Loss of Sfpq Causes Long-Gene Transcriptopathy in the Brain (41 citations)
  • In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids (31 citations)
  • DYRK1A and cognition: A lifelong relationship (23 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • DNA

Masatoshi Hagiwara mainly focuses on Gene, Neurodevelopmental disorder, Transcriptome, Intron and Cancer research. His research on Gene often connects related topics like Cell biology. In his study, Induced pluripotent stem cell is strongly linked to Single-cell analysis, which falls under the umbrella field of Cell biology.

His Intron study integrates concerns from other disciplines, such as Frameshift mutation, RNA splicing, Gene knockdown and Incontinentia pigmenti. His Cancer research research includes elements of Immune checkpoint, Cancer cell, Ductal cells, Fatty acid and Regulation of gene expression. His research on Transcription also deals with topics like

  • Transcriptional elongation, which have a strong connection to Kinase,
  • Dystrophin that connect with fields like Gene expression.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Phosphorylated CREB binds specifically to the nuclear protein CBP

John C. Chrivia;Roland P. S. Kwok;Ned Lamb;Masatoshi Hagiwara.
Nature (1993)

2628 Citations

Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.

Takashi Chijiwa;Atsushi Mishima;Masatoshi Hagiwara;Mamoru Sano.
Journal of Biological Chemistry (1990)

2230 Citations

KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II

Hiroshi Tokumitsu;Takashi Chijiwa;Masatoshi Hagiwara;Akihiro Mizutani.
Journal of Biological Chemistry (1990)

928 Citations

Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.

Daisuke Kaida;Hajime Motoyoshi;Etsu Tashiro;Takayuki Nojima.
Nature Chemical Biology (2007)

635 Citations

Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB

Masatoshi Hagiwara;Arthur Alberts;Paul Brindle;Judy Meinkoth.
Cell (1992)

596 Citations

The newly synthesized selective Ca2+calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells

Mariko Sumi;Kazutoshi Kiuchi;Tomohiko Ishikawa;Akira Ishii.
Biochemical and Biophysical Research Communications (1991)

587 Citations

A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3.

Tetsuo Moriguchi;Noriyo Kuroyanagi;Kyoko Yamaguchi;Yukiko Gotoh.
Journal of Biological Chemistry (1996)

586 Citations

Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A

M Hagiwara;P Brindle;A Harootunian;R Armstrong.
Molecular and Cellular Biology (1993)

550 Citations

Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks

Michiko Muraki;Bisei Ohkawara;Takamitsu Hosoya;Hiroshi Onogi.
Journal of Biological Chemistry (2004)

303 Citations

A fluorescent indicator for visualizing cAMP-induced phosphorylation in vivo.

Yasuo Nagai;Masami Miyazaki;Ryoko Aoki;Takeru Zama.
Nature Biotechnology (2000)

288 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Masatoshi Hagiwara

Hiroyoshi Hidaka

Hiroyoshi Hidaka

D. Western Therapeutics Institute (Japan)

Publications: 68

Marc Montminy

Marc Montminy

Salk Institute for Biological Studies

Publications: 53

Erich D. Jarvis

Erich D. Jarvis

Rockefeller University

Publications: 47

Laurent Meijer

Laurent Meijer

Perha Pharmaceuticals

Publications: 40

Paolo Sassone-Corsi

Paolo Sassone-Corsi

University of California, Irvine

Publications: 39

Eisuke Nishida

Eisuke Nishida

Kyoto University

Publications: 33

Roger J. Davis

Roger J. Davis

University of Massachusetts Medical School

Publications: 32

Richard H. Goodman

Richard H. Goodman

Oregon Health & Science University

Publications: 31

Michael E. Greenberg

Michael E. Greenberg

Harvard University

Publications: 29

Xiang-Dong Fu

Xiang-Dong Fu

University of California, San Diego

Publications: 27

Minoru Yoshida

Minoru Yoshida

University of Tokyo

Publications: 24

Claudio V. Mello

Claudio V. Mello

Oregon Health & Science University

Publications: 23

Stefan Knapp

Stefan Knapp

Goethe University Frankfurt

Publications: 22

Hiroshi Tokumitsu

Hiroshi Tokumitsu

Okayama University

Publications: 22

David F. Clayton

David F. Clayton

Queen Mary University of London

Publications: 21

Angus C. Nairn

Angus C. Nairn

Yale University

Publications: 21

Trending Scientists

Noah Snavely

Noah Snavely

Cornell University

Collins G. Ntim

Collins G. Ntim

University of Southampton

Paul Reuben Day

Paul Reuben Day

IBM (United States)

Mohsen Kavehrad

Mohsen Kavehrad

Pennsylvania State University

Jacobo Bielak

Jacobo Bielak

Carnegie Mellon University

Wojciech Pisula

Wojciech Pisula

Max Planck Society

Feng Jiao

Feng Jiao

University of Delaware

Darío A. Estrin

Darío A. Estrin

National University of Cuyo

Ronald Pierik

Ronald Pierik

Utrecht University

Matthias Dürst

Matthias Dürst

Friedrich Schiller University Jena

Jun Tan

Jun Tan

Guiyang Medical University

Doron Rapaport

Doron Rapaport

University of Tübingen

P H von Hippel

P H von Hippel

University of Oregon

Changyi Chen

Changyi Chen

Baylor College of Medicine

Albert L. Waldo

Albert L. Waldo

Case Western Reserve University

Stephen L. Bacharach

Stephen L. Bacharach

University of California, San Francisco

Something went wrong. Please try again later.